rebamipide (Compound)

Synonyms:rebamipide, 90098-04-7, Proamipide, Mucosta, 111911-87-6, OPC-12759, Rebamipide hydrate, Pramipide, Rebator, 139344-42-6, 2-(4-Chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)propionic acid, 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid, NSC-758955, 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid, LR583V32ZR, DTXSID8045937, MFCD00866895, NCGC00095161-01, 2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid, 2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid, DTXCID6025937, Rebamipidum, Rebamipide [INN:JAN], 2-[(4-chlorobenzoyl)amino]-3-(2-hydroxyquinolin-4-yl)propanoic acid, Rebamipidum [INN-Latin], 4-Quinolinepropanoicacid, a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, 2-[(4-chlorophenyl)formamido]-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid, 4-Quinolinepropanoic acid,a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, (A+/-)-, OPC 12759, CAS-90098-04-7, CCRIS 3585, SR-05000001520, UNII-LR583V32ZR, N-[(4-chlorophenyl)carbonyl]-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine, DisperseRed72, 2-[(4-chlorophenyl)carbonylamino]-3-(2-oxidanylidene-1H-quinolin-4-yl)propanoic acid, Rebamipide-[d4], Mucosta (TN), REBAMIPIDE [MI], REBAMIPIDE [INN], REBAMIPIDE [JAN], Spectrum2_000039, Spectrum3_001959, Rebamipide (JP17/INN), (+-)-2-(4-Chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid, (+-)-1,2-Dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoic acid, REBAMIPIDE [WHO-DD], BSPBio_003559, GTPL871, MLS006011883, SCHEMBL221527, SPECTRUM1505310, SPBio_000137, rebamipide 111911-87-6, CHEMBL1697771, CHEBI:93814, KBio3_002880, OPC-759, HMS1922B20, HMS2090L13, HMS3655L11, HMS3714A15, Pharmakon1600-01505310, BCP07230, HY-B0360, OPC12759, Tox21_111460, BBL011328, CCG-39619, NSC758955, s2032, STK577121, STL146407, 2-(4-Chlorobenzamido)-3-(2-oxo-1,2-dihydro-4-quinolyl)propanoic Acid, AKOS005501649, AKOS005721106, Tox21_111460_1, AC-6841, AC-7588, DB11656, NSC 758955, 2-(4-chloro-benzoylamino)-3-(2-oxo-1,2-dihydro-quinolin-4-yl)-propionic acid, 4-Quinolinepropanoic acid, 1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-, (+-)-, NCGC00095161-02, NCGC00095161-03, NCGC00095161-04, NCGC00095161-05, BC164330, SMR003309276, SY057250, VS-02924, SBI-0207054.P001, FT-0630971, FT-0655225, R0085, SW199113-2, D01121, AB01275518-01, AB01275518_02, AB01275518_03, A802443, A843443, A900081, EN300-19651969, Q-201660, Q7301602, SR-05000001520-1, SR-05000001520-2, SR-05000001520-3, BRD-A15909516-001-02-5, BRD-A15909516-001-03-3, Z2289798874, 2-(4-chlorobenzoylamino)-3-(2-quinolon-4-yl)propionic acid, 2-(4-chlorobenzoylamino)-3-[2(1h)-quinolinon-4-yl] propionic acid, 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid, N-[(4-chlorophenyl)carbonyl]-3-(2-hydroxyquinolin-4-yl)alanine, 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoicacid, 2-(4-chlorobenzoylamino)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propionic acid, 4-Quinolinepropanoicacid,a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, (+/-)-.ALPHA.-(P-CHLOROBENZAMIDO)-1,2-DIHYDRO-2-OXO-4-QUINOLINEPROPIONIC ACID, (+/-)-2-(4-CHLOROBENZOYLAMINO)-3-(2(1H)-QUINOLINON-4-YL)-PROPIONIC ACID, 4-QUINOLINEPROPANOIC ACID, .ALPHA.-((4-CHLOROBENZOYL)AMINO)-1,2-DIHYDRO-2-OXO-
Pubchem:PUBCHEM:5042
Id:2e4ec72e-a1a7-587b-811c-51060b0c2332
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View rebamipide's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for rebamipide.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with rebamipide.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.